BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26778772)

  • 1. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy.
    Mathew RO; Nayer A; Asif A
    J Am Soc Hypertens; 2016 Apr; 10(4):352-9. PubMed ID: 26778772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombomodulin and Endothelial Dysfunction: A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.
    Demeulenaere M; Devreese K; Vanbelleghem H; De Zaeytijd J; Vande Walle J; Van Biesen W; Van Laecke S
    Nephron; 2018; 140(1):63-73. PubMed ID: 29940557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
    van den Born BJ; van der Hoeven NV; Groot E; Lenting PJ; Meijers JC; Levi M; van Montfrans GA
    Hypertension; 2008 Apr; 51(4):862-6. PubMed ID: 18332284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy.
    Fakhouri F; Vercel C; Frémeaux-Bacchi V
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2100-6. PubMed ID: 22879435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ; Moliterno AR
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of thrombotic microangiopathy: insights from animal models.
    Richards A; Kavanagh D
    Nephron Exp Nephrol; 2009; 113(4):e97-103. PubMed ID: 19684414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alternative pathway of complement and the thrombotic microangiopathies.
    Teoh CW; Riedl M; Licht C
    Transfus Apher Sci; 2016 Apr; 54(2):220-31. PubMed ID: 27160864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endothelial cell injury in thrombotic microangiopathy.
    Goldberg RJ; Nakagawa T; Johnson RJ; Thurman JM
    Am J Kidney Dis; 2010 Dec; 56(6):1168-74. PubMed ID: 20843591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the genetics of thrombotic microangiopathies.
    Vieira-Martins P; El Sissy C; Bordereau P; Gruber A; Rosain J; Fremeaux-Bacchi V
    Transfus Apher Sci; 2016 Apr; 54(2):212-9. PubMed ID: 27177491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of endotheliotropic (hemolytic) nephroangiopathy].
    Renner E; Cohen S
    Verh Dtsch Ges Pathol; 1989; 73():169-80. PubMed ID: 2482603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathy: new insights.
    Benz K; Amann K
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):242-7. PubMed ID: 20186056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies.
    Ruiz-Torres MP; Casiraghi F; Galbusera M; Macconi D; Gastoldi S; Todeschini M; Porrati F; Belotti D; Pogliani EM; Noris M; Remuzzi G
    Thromb Haemost; 2005 Mar; 93(3):443-52. PubMed ID: 15735793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathies and the linkage between von Willebrand factor and the alternative complement pathway.
    Turner N; Nolasco L; Nolasco J; Sartain S; Moake J
    Semin Thromb Hemost; 2014 Jul; 40(5):544-50. PubMed ID: 24967890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.
    Keir L; Coward RJ
    Pediatr Nephrol; 2011 Apr; 26(4):523-33. PubMed ID: 20949284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoinositide 3-kinase β mediates microvascular endothelial repair of thrombotic microangiopathy.
    Haddad G; Zhabyeyev P; Farhan M; Zhu LF; Kassiri Z; Rayner DC; Vanhaesebroeck B; Oudit GY; Murray AG
    Blood; 2014 Sep; 124(13):2142-9. PubMed ID: 25139353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis, Microangiopathies, and Inflammation.
    Matevosyan K; Sarode R
    Semin Thromb Hemost; 2015 Sep; 41(6):556-62. PubMed ID: 26276936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.